# Official Journal C 360/2022

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 360 |
| | |
| English edition | Information and Notices | Volume 6520 September 2022 |

ISSN 1977-091X

Official Journal

of the European Union

C 360

English edition

Information and Notices

Volume 6520 September 2022

---

| Contents | page |
| --- | --- |
| | II   Information |
| | INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2022/C 360/01 | Non-opposition to a notified concentration (Case M.10856 – OAKTREE / CPP INVESTMENTS / PORTS AMERICA) (
  1
  ) | 1 |
| 2022/C 360/02 | Non-opposition to a notified concentration (Case M.10737 – HP / POLY) (
  1
  ) | 2 |
| 2022/C 360/03 | Non-opposition to a notified concentration (Case M.10848 – PERMIRA / H&F / ZENDESK) (
  1
  ) | 3 |
| 2022/C 360/04 | Non-opposition to a notified concentration (Case M.10844 – INFRAVIA / P4 / FIBERFORCE) (
  1
  ) | 4 |
| 2022/C 360/05 | Non-opposition to a notified concentration (Case M.10805 – MDP / HPS / PREMFINA / iGO4) (
  1
  ) | 5 |

Contents

page

II   Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2022/C 360/01

Non-opposition to a notified concentration (Case M.10856 – OAKTREE / CPP INVESTMENTS / PORTS AMERICA) (
  1
  )

1

1

2022/C 360/02

Non-opposition to a notified concentration (Case M.10737 – HP / POLY) (
  1
  )

1

2

2022/C 360/03

Non-opposition to a notified concentration (Case M.10848 – PERMIRA / H&F / ZENDESK) (
  1
  )

1

3

2022/C 360/04

Non-opposition to a notified concentration (Case M.10844 – INFRAVIA / P4 / FIBERFORCE) (
  1
  )

1

4

2022/C 360/05

Non-opposition to a notified concentration (Case M.10805 – MDP / HPS / PREMFINA / iGO4) (
  1
  )

1

5

---

| | IV   Notices |
| --- | --- |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2022/C 360/06 | Euro exchange rates — 19 September 2022 | 6 |
| 2022/C 360/07 | Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)
  (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006)
   (
  1
  ) | 7 |

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2022/C 360/06

Euro exchange rates — 19 September 2022

6

2022/C 360/07

Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)
  (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006)
   (
  1
  )

(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006

1

7

---

| | V   Announcements |
| --- | --- |
| | PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
| | European Commission |
| 2022/C 360/08 | Prior notification of a concentration (Case M.10640 – SAFRAN / MBDA / COMPAGNIE INDUSTRIELLE DES LASERS CILAS) (
  1
  ) | 8 |

V   Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

2022/C 360/08

Prior notification of a concentration (Case M.10640 – SAFRAN / MBDA / COMPAGNIE INDUSTRIELLE DES LASERS CILAS) (
  1
  )

1

8

---

| | |
| --- | --- |
| | (1)   Text with EEA relevance. |

---

(1)   Text with EEA relevance.

1

| EN | |
| --- | --- |

EN

---

II Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

| 20.9.2022 | EN | Official Journal of the European Union | C 360/1 |
| --- | --- | --- | --- |

20.9.2022

EN

Official Journal of the European Union

C 360/1

---

Non-opposition to a notified concentration

(Case M.10856 – OAKTREE / CPP INVESTMENTS / PORTS AMERICA)

(Text with EEA relevance)

(2022/C 360/01)

On 9 September 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10856. EUR-Lex is the online point of access to European Union law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10856. EUR-Lex is the online point of access to European Union law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---

| 20.9.2022 | EN | Official Journal of the European Union | C 360/2 |
| --- | --- | --- | --- |

20.9.2022

EN

Official Journal of the European Union

C 360/2

---

Non-opposition to a notified concentration

(Case M.10737 – HP / POLY)

(Text with EEA relevance)

(2022/C 360/02)

On 8 July 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10737. EUR-Lex is the online point of access to European Union law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10737. EUR-Lex is the online point of access to European Union law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---

| 20.9.2022 | EN | Official Journal of the European Union | C 360/3 |
| --- | --- | --- | --- |

20.9.2022

EN

Official Journal of the European Union

C 360/3

---

Non-opposition to a notified concentration

(Case M.10848 – PERMIRA / H&F / ZENDESK)

(Text with EEA relevance)

(2022/C 360/03)

On 9 September 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10848. EUR-Lex is the online point of access to European Union law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10848. EUR-Lex is the online point of access to European Union law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---

| 20.9.2022 | EN | Official Journal of the European Union | C 360/4 |
| --- | --- | --- | --- |

20.9.2022

EN

Official Journal of the European Union

C 360/4

---

Non-opposition to a notified concentration

(Case M.10844 – INFRAVIA / P4 / FIBERFORCE)

(Text with EEA relevance)

(2022/C 360/04)

On 8 September 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10844. EUR-Lex is the online point of access to European Union law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10844. EUR-Lex is the online point of access to European Union law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---

| 20.9.2022 | EN | Official Journal of the European Union | C 360/5 |
| --- | --- | --- | --- |

20.9.2022

EN

Official Journal of the European Union

C 360/5

---

Non-opposition to a notified concentration

(Case M.10805 – MDP / HPS / PREMFINA / iGO4)

(Text with EEA relevance)

(2022/C 360/05)

On 5 August 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10805. EUR-Lex is the online point of access to European Union law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10805. EUR-Lex is the online point of access to European Union law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---

IV Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

| 20.9.2022 | EN | Official Journal of the European Union | C 360/6 |
| --- | --- | --- | --- |

20.9.2022

EN

Official Journal of the European Union

C 360/6

---

Euro exchange rates (1)

19 September 2022

(2022/C 360/06)

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 0,9990 |
| JPY | Japanese yen | 143,42 |
| DKK | Danish krone | 7,4373 |
| GBP | Pound sterling | 0,87785 |
| SEK | Swedish krona | 10,7993 |
| CHF | Swiss franc | 0,9658 |
| ISK | Iceland króna | 139,90 |
| NOK | Norwegian krone | 10,2826 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 24,494 |
| HUF | Hungarian forint | 400,85 |
| PLN | Polish zloty | 4,7058 |
| RON | Romanian leu | 4,9300 |
| TRY | Turkish lira | 18,2738 |
| AUD | Australian dollar | 1,4950 |
| CAD | Canadian dollar | 1,3294 |
| HKD | Hong Kong dollar | 7,8416 |
| NZD | New Zealand dollar | 1,6807 |
| SGD | Singapore dollar | 1,4082 |
| KRW | South Korean won | 1 391,82 |
| ZAR | South African rand | 17,7267 |
| CNY | Chinese yuan renminbi | 7,0066 |
| HRK | Croatian kuna | 7,5215 |
| IDR | Indonesian rupiah | 14 975,43 |
| MYR | Malaysian ringgit | 4,5455 |
| PHP | Philippine peso | 57,347 |
| RUB | Russian rouble | |
| THB | Thai baht | 36,983 |
| BRL | Brazilian real | 5,2886 |
| MXN | Mexican peso | 20,1130 |
| INR | Indian rupee | 79,6530 |

Currency

Exchange rate

USD

US dollar

0,9990

JPY

Japanese yen

143,42

DKK

Danish krone

7,4373

GBP

Pound sterling

0,87785

SEK

Swedish krona

10,7993

CHF

Swiss franc

0,9658

ISK

Iceland króna

139,90

NOK

Norwegian krone

10,2826

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

24,494

HUF

Hungarian forint

400,85

PLN

Polish zloty

4,7058

RON

Romanian leu

4,9300

TRY

Turkish lira

18,2738

AUD

Australian dollar

1,4950

CAD

Canadian dollar

1,3294

HKD

Hong Kong dollar

7,8416

NZD

New Zealand dollar

1,6807

SGD

Singapore dollar

1,4082

KRW

South Korean won

1 391,82

ZAR

South African rand

17,7267

CNY

Chinese yuan renminbi

7,0066

HRK

Croatian kuna

7,5215

IDR

Indonesian rupiah

14 975,43

MYR

Malaysian ringgit

4,5455

PHP

Philippine peso

57,347

RUB

Russian rouble

THB

Thai baht

36,983

BRL

Brazilian real

5,2886

MXN

Mexican peso

20,1130

INR

Indian rupee

79,6530

---

(1)  Source: reference exchange rate published by the ECB.

---

| 20.9.2022 | EN | Official Journal of the European Union | C 360/7 |
| --- | --- | --- | --- |

20.9.2022

EN

Official Journal of the European Union

C 360/7

---

Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1))

(Text with EEA relevance)

(2022/C 360/07)

Decision granting an authorisation

| Reference of the decision (2) | Date of decision | Substance name | Holder(s) of the authorisation | Authorisation number | Authorised use | Date of expiry of review period | Reasons for the decision |
| --- | --- | --- | --- | --- | --- | --- | --- |
| C(2022) 6463 | 13 September 2022 | 4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated
  (4-tert-OPnEO)
  EC No: -, CAS No:- | Pfizer Manufacturing Belgium NV, Rijksweg 12, 2870 Puurs, Belgium | REACH/22/27/0 | As a surfactant within a lubricant used in the manufacture of pharmaceutical drug products | 4 January 2030 | In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the uses of the substance and there are no suitable alternative substances or technologies. |

Reference of the decision (2)

Date of decision

Substance name

Holder(s) of the authorisation

Authorisation number

Authorised use

Date of expiry of review period

Reasons for the decision

C(2022) 6463

13 September 2022

4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated

(4-tert-OPnEO)

EC No: -, CAS No:-

Pfizer Manufacturing Belgium NV, Rijksweg 12, 2870 Puurs, Belgium

REACH/22/27/0

As a surfactant within a lubricant used in the manufacture of pharmaceutical drug products

4 January 2030

In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the uses of the substance and there are no suitable alternative substances or technologies.

---

(1)  OJ L 396, 30.12.2006, p. 1.

(2)  The decision is available on the European Commission website at: Authorisation (europa.eu).

---

V Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

| 20.9.2022 | EN | Official Journal of the European Union | C 360/8 |
| --- | --- | --- | --- |

20.9.2022

EN

Official Journal of the European Union

C 360/8

---

Prior notification of a concentration

(Case M.10640 – SAFRAN / MBDA / COMPAGNIE INDUSTRIELLE DES LASERS CILAS)

(Text with EEA relevance)

(2022/C 360/08)

1.

This notification concerns the following undertakings:

| — | Safran Electronics & Defense (‘SED’, France), owned by Safran S.A. (‘Safran’, France), the parent company of the Safran Group, |
| --- | --- |

—

Safran Electronics & Defense (‘SED’, France), owned by Safran S.A. (‘Safran’, France), the parent company of the Safran Group,

| — | MBDA France (‘MBDA’, France), a wholly-owned subsidiary of MBDA S.A.S (France), itself indirectly jointly controlled by Airbus SE (Netherlands) (37,5 %), BAE Systems plc (United Kingdom) (37,5 %) and Leonardo S.p.A (Italy) (25 %), |
| --- | --- |

—

MBDA France (‘MBDA’, France), a wholly-owned subsidiary of MBDA S.A.S (France), itself indirectly jointly controlled by Airbus SE (Netherlands) (37,5 %), BAE Systems plc (United Kingdom) (37,5 %) and Leonardo S.p.A (Italy) (25 %),

| — | Compagnie Industrielle des Lasers Cilas (‘Cilas’, France), indirectly controlled by ArianeGroup Holding (France). |
| --- | --- |

—

Compagnie Industrielle des Lasers Cilas (‘Cilas’, France), indirectly controlled by ArianeGroup Holding (France).

SED and MBDA will acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of Cilas.

The concentration is accomplished by way of purchase of shares.

2.

| — | SED operates in the field of optronics, avionics, electronics and critical software with civil and military applications on land, at sea, in the air and in space, |
| --- | --- |

—

SED operates in the field of optronics, avionics, electronics and critical software with civil and military applications on land, at sea, in the air and in space,

| — | MBDA operates in the defense sector. Its field of activity includes the design, manufacture and marketing of missiles and weapon systems, |
| --- | --- |

—

MBDA operates in the defense sector. Its field of activity includes the design, manufacture and marketing of missiles and weapon systems,

| — | Cilas develops, manufactures and markets a wide range of products and systems for defense, major scientific laser programs and scientific and industrial instrumentation. |
| --- | --- |

—

Cilas develops, manufactures and markets a wide range of products and systems for defense, major scientific laser programs and scientific and industrial instrumentation.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10640 – SAFRAN / MBDA / COMPAGNIE INDUSTRIELLE DES LASERS CILAS

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

---